Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of 18F-Fluoride Metabolic Flux Than with Measurement of 18F-Fluoride PET/CT SUV?-Reference-Cited by-同舟云学术

Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of 18F-Fluoride Metabolic Flux Than with Measurement of 18F-Fluoride PET/CT SUV?

Published:2018-07-24 Issue:3 Volume:60 Page:322-327
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Azad Gurdip K.,Siddique Musib,Taylor Benjamin,Green Adrian,O’Doherty Jim,Gariani Joanna,Blake Glen M.,Mansi Janine,Goh Vicky,Cook Gary J.R.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference38 articles.

1. Skeletal metastases from breast cancer: uptake of 18 F-fluoride measured with positron emission tomography in correlation with CT

2. Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET;Schiepers;J Nucl Med.,1997

3. Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry

4. Assessment of porcine bone metabolism by dynamic [18F]fluoride ion PET: correlation with bone histomorphometry;Piert;J Nucl Med.,2001

5. Kinetic Analysis of 18F-Fluoride PET Images of Breast Cancer Bone Metastases

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear medicine imaging for bone metastases assessment: what else besides bone scintigraphy in the era of personalized medicine?;Frontiers in Medicine;2024-01-15

2. Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response;Journal of Clinical Medicine;2023-12-27

3. [18F]NaF PET/CT imaging of response to single fraction SABR to bone metastases from breast cancer;Frontiers in Nuclear Medicine;2023-10-04

4. Utility of a simplified [18F] sodium fluoride PET imaging method to quantify bone metabolic flux for a wide range of clinical applications;Frontiers in Endocrinology;2023-09-13

5. Pseudoprogression after advanced first-line endocrine therapy in metastatic breast cancer with bone metastasis: A case report;Frontiers in Oncology;2023-01-04